Research Article
Emergency Tracheal Intubation in Patients with COVID-19: Experience from a UK Centre
Table 1
Baseline patient characteristics prior to tracheal intubation. Data are expressed as n/N (%) or median with interquartile range (IQR).
| | Patient demographics | | | Age | 57 (53–67) | | Male gender | 41/53 (77%) |
| | Patient premorbid medical conditions | | | Cardiovascular diseases | 25/53 (47%) | | Hypertension | 19 (36%) | | Atrial fibrillation | 4 (8%) | | Ischaemic heart disease | 2 (4%) | | Obesity (BMI>30 kg/m2) | 20/53 (38%) | | Respiratory disease | 19/53 (36%) | | Diabetes | 14/53 (26%) |
| | Mode of oxygen delivery prior to intubation team arrival | | | Continuous positive airway pressure | 32/53 (60%) | | <2 days | 18/53 (34%) | | >2 days | 15/53 (28%) | | High-flow oxygen therapy | 20/53 (38%) | | Non-rebreathe mask | 19/53 (36%) | | Nasal cannulae | 1/53 (2%) |
| | Degree of hypoxia prior to intubation team arrival | SpO2 /FIO2 ratio | | All patients (N = 53) | 96 (92–119) | | Continuous positive airway pressure <2 days (18/53) | 96 (92–110) | | Continuous positive airway pressure >2 days (15/53) | 95 (92–119) | | High-flow oxygen therapy (20/53) | 101 (94–133) |
|
|
